SCHEMBL8939989

SCHEMBL8939989

CC1(C)Cc2c(Cl)ccc(C(=O)O)c2O1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGES O14684 8/20 0.39
PKM P14618 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 4/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
POLB P06746 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
CASP1 P29466 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
AKR1B1 P15121 1/20 0.35
LMNA P02545 1/20 0.34
ALOX5 P09917 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4242110 0.84 NPSR1 (0.39) PTGESPKMNPSR1ALDH1A1CYP1A2
SCHEMBL8126374 0.83 PARP1 (0.40) PTGESPKMNPSR1ALDH1A1CYP3A4
SCHEMBL8940054 0.79 FFAR4 (0.44) ALDH1A1CASP1KMT2ALMNA
SCHEMBL5042504 0.78 PTGES (0.37) PTGESPKMNPSR1ALDH1A1POLB
SCHEMBL11218997 0.77 ALDH1A1 (0.36) PTGESPKMNPSR1ALDH1A1CYP1A2
SCHEMBL11956874 0.76 PARP1 (0.37) PKMNPSR1ALDH1A1CYP3A4POLB
SCHEMBL8125096 0.76 MEN1 (0.40) PTGESPKMNPSR1ALDH1A1CYP1A2
SCHEMBL8940038 0.76 TPMT (0.39) PTGESALDH1A1POLBMEN1KMT2A
SCHEMBL8948519 0.75 ALDH1A1 (0.37) PKMNPSR1ALDH1A1CYP1A2CYP3A4
SCHEMBL14444109 0.75 ALDH1A1 (0.46) PKMNPSR1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5563148-A BICYCLIC ESTERS OR AMIDES; USED IN TREATING MIGRAINE, EMESIS, GASTROINTESTINAL DISORDERS, SCHIZOPHRENIA OR ANXIETY IN MAMMALS ELI LILLY AND COMPANY (US) 1996-10-08 US disclosed
EP-0307172-B1 Improvements in or relating to specific 5-HT3 antagonists LILLY CO ELI (US) 1995-10-11 EP disclosed
US-5442078-A Intermediates for specific 5-HT3 antagonists ELI LILLY AND COMPANY (US) 1995-08-15 US disclosed
US-5364863-A Treatment of migraine, emesis, schizophrenia, anxiety, gastrointestinal disorders ELI LILLY AND COMPANY (US) 1994-11-15 US disclosed
US-4997956-A Analgesics ELI LILLY AND COMPANY (US) 1991-03-05 US disclosed
US-4921982-A 5-halo-2,3-dihydro-2,2-dimethylbenzofuran-7-carboxylic acids useful as intermediates for 5-HT3 antagonists ELI LILLY AND COMPANY (US) 1990-05-01 US disclosed
CN-1031841-A The improvement of special 5-HT3 antagonist LILLY CO ELI (US) 1989-03-22 CN disclosed
EP-0307172-A2 Improvements in or relating to specific 5-HT3 antagonists ELI LILLY AND COMPANY (US) 1989-03-15 EP disclosed